Royce & Associates’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Royce & Associates’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,200	Closed	-$68K	–	1211
2020 Q2	$68K	Hold	5,200	–	–	﹤0.01%	1006
2020 Q1	$48K	Hold	5,200	–	–	﹤0.01%	1015
2019 Q4	$86K	Buy	+5,200	New	+$84.3K	﹤0.01%	999

Other funds holding OXFD

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Alyeska Investment Group

Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return